tiprankstipranks
Addex Therapeutics (ADXN)
NASDAQ:ADXN
US Market
ADXN
Addex Therapeutics
RESEARCH TOOLSreports
Want to see ADXN full AI Analyst Report?

Addex Therapeutics (ADXN) Income Statement

82 Followers

Addex Therapeutics Income Statement

Last quarter (Q4 2025), Addex Therapeutics's total revenue was CHF19.81K, an increase of Infinity% from the same quarter last year. In Q4, Addex Therapeutics's net income was CHF-2.30M. See Addex Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Mar 25Mar 24Dec 22Dec 21
Total Revenue
CHF 208.14KCHF 404.10KCHF 1.61MCHF 1.42MCHF 2.92M
Gross Profit
CHF 197.94KCHF 404.10KCHF 1.61MCHF 1.42MCHF 2.92M
Operating Expenses
CHF 3.59MCHF 3.16MCHF 3.86MCHF 11.96MCHF 18.42M
Depreciation and Amortization
CHF 10.20KCHF 260.12KCHF 305.95KCHF 323.14KCHF 347.61K
EBITDA
CHF -3.38MCHF -4.65MCHF -2.19MCHF -10.45MCHF -14.94M
Operating Income
CHF -3.39MCHF -2.76MCHF -2.24MCHF -10.54MCHF -15.51M
Other Income/Expenses
CHF -4.85MCHF -2.15MCHF -257.19KCHF -263.06KCHF 154.00K
Pretax Income
CHF -8.24MCHF -4.91MCHF -2.50MCHF -10.80MCHF -15.35M
Net Income
CHF -8.10MCHF 7.06MCHF -10.56MCHF -20.80MCHF -15.35M
Per Share Metrics
Basic EPS
CHF -6.88CHF 8.40CHF -16.80CHF -55.20CHF -54.00
Diluted EPS
CHF -6.88CHF 8.40CHF -16.80CHF -55.20CHF -54.00
Weighted Average Shares Outstanding
 935.00K 817.61K 619.23K 376.54K 284.33K
Weighted Average Shares Outstanding (Diluted)
 935.00K 817.61K 619.23K 376.54K 284.33K
Currency in CHF

Addex Therapeutics Earnings and Revenue History